The Munich-based chemical company WACKER acquires a 60 percent stake in specialty silane manufacturer SICO Performance Material Co., Ltd, Jining (China).
Prokarium, a biopharmaceutical company pioneering the oncology field of microbial immunotherapy, and Wacker Biotech announced today that they had signed a contract for the manufacturing of Prokarium’s microbial novel immunotherapy for bladder cancer.
CureVac N.V., a company based in Tübingen, Germany, needs less production capacity for CVnCOV, its mRNA vaccine candidate against Covid-19.
Wacker Chemie AG and the Finsterwalder Corporate Group intend to significantly expand their collaboration.
Wacker Chemie AG closed Q2 2021 with significant increases in both sales and earnings.